RISK OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) WITH PRIOR SKIN INVOLVEMENT

MICHEL G BOULAD F SMALL T BLACK P HELLER G CHILDS B CASTROMALASPINA H GILLIO A MACKINNON S PAPADOPOULOS E YOUNG J KERNAN NA OREILLY RJ

G. Michel et al., RISK OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) WITH PRIOR SKIN INVOLVEMENT, Blood, 84(10), 1994, pp. 10000207-10000207

NO

Hematology

Blood → ACNP

00064971

84

10

1994

1

10000207 - 10000207

ISI

0006-4971(1994)84:10<10000207:RORAAB>2.0.ZU;2-9